Home › Compare › QTXB vs DVY

QTXB vs DVY: Dividend Comparison 2026

QTXB yields 400000.00% · DVY yields 3.50%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 QTXB wins by $5.011119029548644e+32M in total portfolio value
10 years
QTXB
QTXB
● Live price
400000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.011119029548644e+32M
Annual income
$500,865,583,351,836,840,000,000,000,000,000,000,000.00
Full QTXB calculator →
DVY
DVY
● Live price
3.50%
Share price
$150.03
Annual div
$5.25
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.1K
Annual income
$437.78
Full DVY calculator →

Portfolio growth — QTXB vs DVY

📍 QTXB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodQTXBDVY
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, QTXB + DVY cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
QTXB pays
DVY pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QTXB
Annual income on $10K today (after 15% tax)
$34,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$425,735,745,849,061,300,000,000,000,000,000,000,000.00/yr
DVY
Annual income on $10K today (after 15% tax)
$297.17/yr
After 10yr DRIP, annual income (after tax)
$372.11/yr
At 15% tax rate, QTXB beats the other by $425,735,745,849,061,300,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QTXB + DVY for your $10,000?

QTXB: 50%DVY: 50%
100% DVY50/50100% QTXB
Portfolio after 10yr
$2.505559514774322e+32M
Annual income
$250,432,791,675,918,420,000,000,000,000,000,000,000.00/yr
Blended yield
99.95%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QTXB buys
0
DVY buys
0
No recent congressional trades found for QTXB or DVY in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricQTXBDVY
Forward yield400000.00% ✓3.50%
Annual dividend / share$2.00$5.25 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$5.011119029548644e+32M$25.1K ✓
Annual income after 10y$500,865,583,351,836,840,000,000,000,000,000,000,000.00 ✓$437.78
Total dividends collected$5.010957816668433e+32M ✓$4.0K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: QTXB vs DVY ($10,000, DRIP)

YearQTXB PortfolioQTXB Income/yrDVY PortfolioDVY Income/yrGap
1← crossover$40,010,700$40,000,000.00$11,050$349.62+$40.00M → QTXB
2$149,615,521,729$149,572,710,280.37$12,184$361.04+$149615.51M → QTXB
3$522,880,052,725,200$522,719,964,116,949.25$13,409$372.07+$522880052.71M → QTXB
4$1,707,862,989,289,045,000$1,707,303,507,632,628,700.00$14,730$382.68+$1707862989289.03M → QTXB
5$5,213,509,402,845,684,000,000$5,211,681,989,447,144,000,000.00$16,154$392.89+$5213509402845684.00M → QTXB
6$14,874,219,058,409,543,000,000,000$14,868,640,603,348,497,000,000,000.00$17,688$402.69+$14874219058409543680.00M → QTXB
7$39,661,196,234,050,755,000,000,000,000$39,645,280,819,658,260,000,000,000,000.00$19,338$412.07+$3.966119623405075e+22M → QTXB
8$98,838,436,350,327,300,000,000,000,000,000$98,795,998,870,356,880,000,000,000,000,000.00$21,113$421.04+$9.88384363503273e+25M → QTXB
9$230,205,236,474,344,900,000,000,000,000,000,000$230,099,479,347,450,050,000,000,000,000,000,000.00$23,020$429.61+$2.302052364743449e+29M → QTXB
10$501,111,902,954,864,400,000,000,000,000,000,000,000$500,865,583,351,836,840,000,000,000,000,000,000,000.00$25,070$437.78+$5.011119029548644e+32M → QTXB

QTXB vs DVY: Complete Analysis 2026

QTXB — Stock

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.

Full QTXB Calculator →

DVY — ETF

The iShares Select Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full DVY Calculator →
📬

Get this QTXB vs DVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QTXB vs SCHDQTXB vs JEPIQTXB vs OQTXB vs KOQTXB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.